Fertility Sparing Surgery for Localized Ovarian Cancers Maintains an Ability to Conceive, but is Associated With Diminished Reproductive Potential. Issue 1 (July 2015)

• Record Type: Journal Article
• Authors: Letourneau, Joseph; Chan, Jessica; Salem, Wael; Chan, Sai‐Wing; Shah, Meera; Ebbel, Erin; McCulloch, Charles; Chen, Lee‐May; Cedars, Marcelle; Rosen, Mitchell
• Is Part Of: Journal of surgical oncology. Volume 112:Issue 1(2015:Jul. 01)
• Page Start: 26
• Page End: 30
• Publication Date: 2015-07
• Subjects: Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.23942
• Languages: English
• ISSNs: 0022-4790

Abstract

<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jso23942-sec-0001" sec-type="section"> <title>Background</title> <p>Little is known about fertility outcomes after fertility sparing surgery (FSS) for localized ovarian cancers.</p> </sec> <sec id="jso23942-sec-0002" sec-type="section"> <title>Methods</title> <p>A random sample of 783 women treated for ovarian cancer were identified from the California Cancer Registry for survey (age 18–40 years at diagnosis; diagnosed from 1993–2007). We evaluated outcomes including post‐treatment amenorrhea, infertility, early menopause (age <45), and disease recurrence. Logistic regression was used to determine the probability of amenorrhea, infertility, and recurrence. Censored data methods were used to determine the probability of early menopause.</p> </sec> <sec id="jso23942-sec-0003" sec-type="section"> <title>Results</title> <p>A total of 382 women replied. One hundred and sixteen and 266 completed our survey. Two hundred and forty‐five reported treatment with potential to impact fertility (i.e., systemic chemotherapy ± radiation/surgery to the abdomen/pelvis). A total of 125 had disease/stage eligible for FSS and 82 (66%) underwent FSS. While many who attempted conception did conceive, 32% did not. Younger age at diagnosis was associated with higher rates of early menopause (<italic>P</italic> < 0.001) after FSS. Recurrence rates for those undergoing FSS were 8–10%, while none of the women who underwent non‐FSS surgery had a recurrence.</p> </sec> <sec id="jso23942-sec-0004" sec-type="section"> <title>Conclusions</title> <p>FSS maintains an ability to conceive for most patients. However, after FSS, there may be risks of infertility, early menopause with earlier age of treatment, and increased probability of disease recurrence. <italic>J. Surg. Oncol. 2015 111:26–30</italic>. © 2015 Wiley Periodicals, Inc.</p> </sec> </abstract>